154 related articles for article (PubMed ID: 36419348)
1. A KCNC1-related neurological disorder due to gain of Kv3.1 function.
Clatot J; Ginn N; Costain G; Goldberg EM
Ann Clin Transl Neurol; 2023 Jan; 10(1):111-117. PubMed ID: 36419348
[TBL] [Abstract][Full Text] [Related]
2. Progressive myoclonus epilepsy KCNC1 variant causes a developmental dendritopathy.
Carpenter JC; Männikkö R; Heffner C; Heneine J; Sampedro-Castañeda M; Lignani G; Schorge S
Epilepsia; 2021 May; 62(5):1256-1267. PubMed ID: 33735526
[TBL] [Abstract][Full Text] [Related]
3. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
Nascimento FA; Andrade DM
Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
[TBL] [Abstract][Full Text] [Related]
4. KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.
Park J; Koko M; Hedrich UBS; Hermann A; Cremer K; Haberlandt E; Grimmel M; Alhaddad B; Beck-Woedl S; Harrer M; Karall D; Kingelhoefer L; Tzschach A; Matthies LC; Strom TM; Ringelstein EB; Sturm M; Engels H; Wolff M; Lerche H; Haack TB
Ann Clin Transl Neurol; 2019 Jul; 6(7):1319-1326. PubMed ID: 31353862
[TBL] [Abstract][Full Text] [Related]
5. Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations.
Cameron JM; Maljevic S; Nair U; Aung YH; Cogné B; Bézieau S; Blair E; Isidor B; Zweier C; Reis A; Koenig MK; Maarup T; Sarco D; Afenjar A; Huq AHMM; Kukolich M; Billette de Villemeur T; Nava C; Héron B; Petrou S; Berkovic SF
Ann Clin Transl Neurol; 2019 Jul; 6(7):1263-1272. PubMed ID: 31353855
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.
Feng H; Clatot J; Kaneko K; Flores-Mendez M; Wengert ER; Koutcher C; Hoddeson E; Lopez E; Lee D; Arias L; Liang Q; Zhang X; Somarowthu A; Covarrubias M; Gunthorpe MJ; Large CH; Akizu N; Goldberg EM
Cell Rep Med; 2024 Feb; 5(2):101389. PubMed ID: 38266642
[TBL] [Abstract][Full Text] [Related]
7. A KCNC1 mutation in epilepsy of infancy with focal migrating seizures produces functional channels that fail to be regulated by PKC phosphorylation.
Zhang Y; Ali SR; Nabbout R; Barcia G; Kaczmarek LK
J Neurophysiol; 2021 Aug; 126(2):532-539. PubMed ID: 34232791
[TBL] [Abstract][Full Text] [Related]
8. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
Muona M; Berkovic SF; Dibbens LM; Oliver KL; Maljevic S; Bayly MA; Joensuu T; Canafoglia L; Franceschetti S; Michelucci R; Markkinen S; Heron SE; Hildebrand MS; Andermann E; Andermann F; Gambardella A; Tinuper P; Licchetta L; Scheffer IE; Criscuolo C; Filla A; Ferlazzo E; Ahmad J; Ahmad A; Baykan B; Said E; Topcu M; Riguzzi P; King MD; Ozkara C; Andrade DM; Engelsen BA; Crespel A; Lindenau M; Lohmann E; Saletti V; Massano J; Privitera M; Espay AJ; Kauffmann B; Duchowny M; Møller RS; Straussberg R; Afawi Z; Ben-Zeev B; Samocha KE; Daly MJ; Petrou S; Lerche H; Palotie A; Lehesjoki AE
Nat Genet; 2015 Jan; 47(1):39-46. PubMed ID: 25401298
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological rescue of mutated K
Munch AS; Saljic A; Boddum K; Grunnet M; Hougaard C; Jespersen T
Eur J Pharmacol; 2018 Aug; 833():255-262. PubMed ID: 29894724
[TBL] [Abstract][Full Text] [Related]
10. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature.
Barot N; Margiotta M; Nei M; Skidmore C
Epileptic Disord; 2020 Oct; 22(5):654-658. PubMed ID: 32972906
[TBL] [Abstract][Full Text] [Related]
11. Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K
Oliver KL; Franceschetti S; Milligan CJ; Muona M; Mandelstam SA; Canafoglia L; Boguszewska-Chachulska AM; Korczyn AD; Bisulli F; Di Bonaventura C; Ragona F; Michelucci R; Ben-Zeev B; Straussberg R; Panzica F; Massano J; Friedman D; Crespel A; Engelsen BA; Andermann F; Andermann E; Spodar K; Lasek-Bal A; Riguzzi P; Pasini E; Tinuper P; Licchetta L; Gardella E; Lindenau M; Wulf A; Møller RS; Benninger F; Afawi Z; Rubboli G; Reid CA; Maljevic S; Lerche H; Lehesjoki AE; Petrou S; Berkovic SF
Ann Neurol; 2017 May; 81(5):677-689. PubMed ID: 28380698
[TBL] [Abstract][Full Text] [Related]
12. A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine.
Ambrosino P; Ragona F; Mosca I; Vannicola C; Canafoglia L; Solazzi R; Rivolta I; Freri E; Granata T; Messina G; Castellotti B; Gellera C; Soldovieri MV; DiFrancesco JC; Taglialatela M
Epilepsia; 2023 Jul; 64(7):e148-e155. PubMed ID: 37203213
[TBL] [Abstract][Full Text] [Related]
13. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
[TBL] [Abstract][Full Text] [Related]
14. A structurally precise mechanism links an epilepsy-associated
Clatot J; Currin CB; Liang Q; Pipatpolkai T; Massey SL; Helbig I; Delemotte L; Vogels TP; Covarrubias M; Goldberg EM
Proc Natl Acad Sci U S A; 2024 Jan; 121(3):e2307776121. PubMed ID: 38194456
[TBL] [Abstract][Full Text] [Related]
15. Loss of Function of KCNC1 is associated with intellectual disability without seizures.
Poirier K; Viot G; Lombardi L; Jauny C; Billuart P; Bienvenu T
Eur J Hum Genet; 2017 May; 25(5):560-564. PubMed ID: 28145425
[TBL] [Abstract][Full Text] [Related]
16. Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes.
Li X; Zheng Y; Li S; Nair U; Sun C; Zhao C; Lu J; Zhang VW; Maljevic S; Petrou S; Lin J
Ann Transl Med; 2021 Sep; 9(18):1397. PubMed ID: 34733949
[TBL] [Abstract][Full Text] [Related]
17. Predicting the functional effects of voltage-gated potassium channel missense variants with multi-task learning.
Boßelmann CM; Hedrich UBS; Müller P; Sonnenberg L; Parthasarathy S; Helbig I; Lerche H; Pfeifer N
EBioMedicine; 2022 Jul; 81():104115. PubMed ID: 35759918
[TBL] [Abstract][Full Text] [Related]
18. Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy.
Li L; Liu Z; Yang H; Li Y; Zeng Q; Chen L; Liu Y; Chen Y; Zhu F; Cao D; Hu J; Shen X
Seizure; 2022 Oct; 101():218-224. PubMed ID: 36087422
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With
Schwarz N; Seiffert S; Pendziwiat M; Rademacher AV; Brünger T; Hedrich UBS; Augustijn PB; Baier H; Bayat A; Bisulli F; Buono RJ; Bruria BZ; Doyle MG; Guerrini R; Heimer G; Iacomino M; Kearney H; Klein KM; Kousiappa I; Kunz WS; Lerche H; Licchetta L; Lohmann E; Minardi R; McDonald M; Montgomery S; Mulahasanovic L; Oegema R; Ortal B; Papacostas SS; Ragona F; Granata T; Reif PS; Rosenow F; Rothschild A; Scudieri P; Striano P; Tinuper P; Tanteles GA; Vetro A; Zahnert F; Goldberg EM; Zara F; Lal D; May P; Muhle H; Helbig I; Weber Y
Neurology; 2022 May; 98(20):e2046-e2059. PubMed ID: 35314505
[TBL] [Abstract][Full Text] [Related]
20. Human
Wei AD; Wakenight P; Zwingman TA; Bard AM; Sahai N; Willemsen MH; Schelhaas HJ; Stegmann APA; Verhoeven JS; de Man SA; Wessels MW; Kleefstra T; Shinde DN; Helbig KL; Basinger A; Wagner VF; Rodriguez-Buritica D; Bryant E; Millichap JJ; Millen KJ; Dobyns WB; Ramirez JM; Kalume FK
J Neurophysiol; 2022 Jul; 128(1):40-61. PubMed ID: 35583973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
